Medistim
Logotype for Medistim

Medistim (MEDI) investor relations material

Medistim Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Medistim
Q3 2026 earnings summary23 Oct, 2026

Executive summary

  • Q3 revenue reached a record NOK 210m, up 25.9% reported and 31.5% currency-neutral; own-product sales rose 34.6% currency-neutral.

  • YTD revenue reached a record NOK 613.7m, up 18.6% reported and 23.6% currency-neutral; own-product sales grew 30.1% currency-neutral.

  • Q3 EBIT rose 55.7% to NOK 63.1m; YTD EBIT increased 20.6% to NOK 185.5m.

Financial highlights

  • Q3 gross margin improved to 84.5% from 81.5%; strong sales and favorable mix supported the increase, alongside a NOK 2.7m net tariff expense.

  • Q3 EBITDA was NOK 70.6m; profit after tax was NOK 47.8m versus NOK 34.7m, and EPS was NOK 2.61 versus NOK 1.90.

  • YTD EBITDA reached NOK 205.2m versus NOK 171.7m; profit after tax was NOK 140.3m versus NOK 121.1m, and EPS was NOK 7.67 versus NOK 6.63.

  • Q3 operating cash flow was NOK 91.5m; YTD operating cash flow was NOK 146.5m, with working capital weighing on the YTD figure.

Segment performance

  • AMERICAS Q3 revenue was NOK 116.9m, up 51.7% currency-neutral, driven by Flow-and-Imaging systems and imaging probes; the U.S. generated ~95% of regional revenue.

  • APAC Q3 revenue was NOK 33.6m, up 44.6% currency-neutral; China and Japan grew, while distributor sales can vary by quarter.

  • EMEA Q3 revenue was NOK 36.9m, up 5.5% currency-neutral; direct markets grew while distributor sales declined 17.5%.

  • Q3 Cardiac sales rose 35.0% to NOK 161.6m; Vascular sales were NOK 25.9m, essentially flat. Imaging sales grew 57.9% to NOK 72.7m and Flow sales rose 15.4% to NOK 114.9m.

  • Flow-and-Imaging system unit sales increased 27%; Flow-only system units rose 22%, Flow probe units grew 8.7%, and imaging probe units rose 30% in AMERICAS.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Medistim earnings date

Logotype for Medistim
Q4 202626 Feb, 2027
Medistim
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Medistim earnings date

Logotype for Medistim
Q4 202626 Feb, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Medistim, ASA engages in the development, production, service, leasing and distribution of medical devices for cardio-vascular surgery in the United States, Europe, Asia and internationally. The company's medical devices comprise of surgical suction systems, anesthesia systems, and cardiopulmonary bypass machines. The company's pacemaker systems are developed for single chamber or dual chamber epiaortic pacing. The systems make use of Medistim's proprietary bipolar lead-less IC technology and provide a comprehensive approach to treating heart failure. Medistim provides its products through distributors, nationally and internationally in all major markets including the United States, Canada, the European Union, Asia, Australia, South Africa and others.